CORTIFOAM

LOE Approaching

hydrocortisone acetate

NDARECTALAEROSOL, METERED
Approved
Feb 1982
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1

Mechanism of Action

CLINICAL PHARMACOLOGY Cortifoam provides effective topical administration of an anti-inflammatory corticosteroid as adjunctive therapy of ulcerative proctitis. Direct observations of methylene blue-containing foam have shown staining about 10 centimeters into the rectum.

Clinical Trials (1)

NCT02671058Phase 1Completed

Pharmacokinetics and Bioavailability of Hydrocortisone Acetate Suppositories

Started Mar 2016
16 enrolled
Healthy